Irfan Gulam Ahmed Dhorajiwala

Irfan Gulam Ahmed Dhorajiwala

Active Director Director DIN 06761631
DIN 06761631 First appointment Feb 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Feb 2014
Shareholding value •••• Premium profile

About Irfan Gulam Ahmed Dhorajiwala

Data last updated:

Irfan Gulam Ahmed Dhorajiwala is a Director at Thaiger Pharma Private Limited (since 2014), Director at Nova Laboratories Private Limited (since 2017) and Director at Thaiger Nutraceuticals Private Limited (since 2017), and holds 2 more current directorships. The companies operate in Pharma, Food and Beverages and Real Estate. The 3 current companies with reported revenue have a combined latest revenue of ₹13.21 Cr; the largest is Thaiger Pharma Private Limited at ₹12.77 Cr (FY 2025).

DIN 06761631
Primary Designation Director
Industry Pharma
First Appointment 17 Feb 2014
Oldest Company Age 12 yrs
Largest company Thaiger Pharma Private Limited · ₹12.77 Cr (FY 2025)
Combined revenue ₹13.21 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Thaiger Pharma Private Limited U24100MH2014PTC253312
Director17 Feb 20142014₹12.77 Cr (FY 2025)Active
Nova Laboratories Private Limited U24304MH2017PTC296093
Director13 Jun 20172017₹28.2 Lakh (FY 2025)Active
Director18 Apr 20172017₹16.5 Lakh (FY 2023)Active
Designated Partner01 Sep 20252024Active
Thaiger Llp ACQ-5594
Designated Partner14 Aug 20252025Active

Directorship timeline

Open interactive timeline →
Thaiger Built It Better Llp
Thaiger Llp
Thaiger Nutraceuticals Private Limited
Thaiger Pharma Private Limited
Premium access

Shareholding and investment profile for Irfan Gulam Ahmed Dhorajiwala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Irfan Gulam Ahmed Dhorajiwala

Irfan Gulam Ahmed Dhorajiwala currently holds 5 directorships: Thaiger Pharma Private Limited (Director, since 17 Feb 2014, revenue ₹12.77 Cr (FY 2025)); Nova Laboratories Private Limited (Director, since 13 Jun 2017, revenue ₹28.2 Lakh (FY 2025)); Thaiger Nutraceuticals Private Limited (Director, since 18 Apr 2017, revenue ₹16.5 Lakh (FY 2023)); Thaiger Built It Better Llp (Designated Partner, since 01 Sep 2025); Thaiger Llp (Designated Partner, since 14 Aug 2025).

Irfan Gulam Ahmed Dhorajiwala was first appointed on 17 Feb 2014 as Director at Thaiger Pharma Private Limited. The most recent appointment on record is 01 Sep 2025 at Thaiger Built It Better Llp.

The 3 current companies of Irfan Gulam Ahmed Dhorajiwala that report revenue have a combined latest revenue of ₹13.21 Cr: Thaiger Pharma Private Limited ₹12.77 Cr (FY 2025); Nova Laboratories Private Limited ₹28.2 Lakh (FY 2025); Thaiger Nutraceuticals Private Limited ₹16.5 Lakh (FY 2023).

The current boards of Irfan Gulam Ahmed Dhorajiwala's companies include Aftab Akhtar Attarwala (Thaiger Pharma Private Limited), Chen Zhanzhi (Nova Laboratories Private Limited), Peter Jerzy Franik (Nova Laboratories Private Limited), Reshma Irfan Ahmed (Nova Laboratories Private Limited), Afzal Mohammed Amin (Thaiger Built It Better Llp), Sikander Hanif Shaikh (Thaiger Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available